Aminoglycoside dosing and monitoring for Pseudomonas aeruginosa during acute pulmonary exacerbations in cystic fibrosis.
Sign Up to like & getrecommendations! Published in 2021 at "Pediatric pulmonology"
DOI: 10.1002/ppul.25441
Abstract: Aminoglycosides are commonly used for the treatment of Pseudomonas aeruginosa (PsA) in the setting of acute pulmonary exacerbations (PEx) in pediatric patients with cystic fibrosis (CF). There are controversies and practice differences between institutions related… read more here.
Keywords: cystic fibrosis; pseudomonas aeruginosa; aminoglycoside dosing; dosing monitoring ... See more keywords
Aminoglycosides’ dosing and monitoring practices in critically ill patients in Quebec hospitals
Sign Up to like & getrecommendations! Published in 2022 at "Journal of Chemotherapy"
DOI: 10.1080/1120009x.2022.2040771
Abstract: Abstract Considering the aminoglycosides’ characteristics in terms of efficacy and toxicity, multiple dosing recommendations and nomograms have been suggested over several decades. The objective is to describe the dosing and monitoring practices of amikacin, gentamicin,… read more here.
Keywords: ill patients; aminoglycosides dosing; critically ill; dosing monitoring ... See more keywords
Systematic review of clinical guidelines and consensus statements concerning heparin and protamine dosing and monitoring of anticoagulation levels for non-cardiac arterial procedures
Sign Up to like & getrecommendations! Published in 2024 at "Vascular"
DOI: 10.1177/17085381241283519
Abstract: Objectives This systematic review was performed to examine all published practice Guidelines and Consensus Statements (together: GCS) on heparin dosing and monitoring during non-cardiac arterial procedures (NCAP). The objective was to scrutinize the recommendations and… read more here.
Keywords: guidelines consensus; review; systematic review; consensus statements ... See more keywords